Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGENOMICS INC Director's Dealing 2017

Jun 26, 2017

32227_dirs_2017-06-26_75dca818-ead6-4095-9f7f-9c46800bccca.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2017-05-25

Reporting Person: BALLIET JENNIFER (VP and Chief Culture Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-06-22 Common Stock S 10723 $8.49 Disposed 0 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $3.76 2018-04-16 Common Stock (7500) 7500 Direct
Stock Option (Right to Buy) $3.45 2019-03-05 Common Stock (15000) 15000 Direct
Stock Option (Right to Buy) $4.78 2020-05-04 Common Stock (120000) 120000 Direct
Stock Option (Right to Buy) $7.15 2021-04-20 Common Stock (50000) 50000 Direct
Stock Option (Right to Buy) $7.52 2022-04-28 Common Stock (60000) 60000 Direct
Restricted Stock $0.00 Common Stock (20000) 20000 Direct

Footnotes

F1: On April 16, 2013, Jennifer Balliet was granted 7,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F2: On March 5, 2014, Jennifer Balliet was granted 15,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.

F3: On May 4, 2015, Jennifer Balliet was granted 120,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.

F4: On April 20, 2016, Jennifer Balliet was granted 50,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F5: On April 28, 2017, Jennifer Balliet was granted 60,000 stock options. The options vest ratably over the first three anniversaries of the grant date.

F6: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.

F7: Restricted stock will vest as follows; 6,666 units will vest on May 25, 2018 and 6,667 units will vest on May 25, 2019 and 2020.

F8: These restricted stock units will terminate upon the earliest of death, termination of employment or the last vesting date.